NIH

November 22, 2013

What makes us human?

Using computational tools to search for the genetic basis of what makes us human, Vanderbilt Assistant Professor of Biomedical Informatics Tony Capra and colleagues at the University of California-San Francisco have identified promising candidate regions.

By Leigh MacMillan
November 21, 2013

Therapeutic target for synovial sarcoma

Inhibitors of a signaling pathway that is critical to synovial sarcoma tumorigenesis may be useful treatments for this aggressive cancer.

By Leigh MacMillan
November 14, 2013

Vanderbilt, Leipzig research collaboration sees strong results

During the past two weeks, the fifth international symposium between Leipzig and Vanderbilt universities was held on the Vanderbilt campus, as seven Leipzig faculty members presented a series of chemical biology-related lectures.

By VUMC News and Communications
November 13, 2013

Molecular circuits in ovarian cancer

Vanderbilt researchers have used bioinformatics analysis of gene expression data to describe molecular “circuits” that drive ovarian cancer.

By Leigh MacMillan
November 11, 2013

Amish aid study of Parkinson genetics

Amish populations are valuable for genetic research because of their isolation, shared ancestry and homogeneous lifestyles.

By Leigh MacMillan
November 8, 2013

Defusing ‘C. diff’ infection

By Leigh MacMillan
November 7, 2013

Neurotransmitter’s role in bone balance

Removal of the neurotransmitter norepinephrine from the space outside cells plays an important role in the regulation of bone remodeling.
By Leigh MacMillan
November 7, 2013

Breast SPORE lands NCI renewal

Vanderbilt-Ingram Cancer Center’s Breast Specialized Program of Research Excellence (SPORE) has been awarded a third round of funding from the National Cancer Institute (NCI).
By VUMC News and Communications
November 7, 2013

VU study sheds new light on DNA replication

David Cortez, Ph.D., and his Vanderbilt colleagues report new findings that shed light on fundamental processes involved in DNA replication and have implications for cancer therapies that target these processes.
By Leigh MacMillan
October 30, 2013

Preserving antibiotic arsenal for TB

Clinicians should be cautious about prescribing newer fluoroquinolone antibiotics to patients with TB risk factors; doing so may jeopardize the use of these agents against TB.
By Leigh MacMillan
October 28, 2013

Tool predicts risk for developmental delays in early childhood

A non-invasive measure of electrical brain activity in preterm infants predicts cognitive and communication functioning during early childhood, according to a new Vanderbilt University study.
By Leigh MacMillan
October 25, 2013

Targets of SIN drive cell division

Vanderbilt researchers have identified a key regulator of cell division.
By Leigh MacMillan
October 24, 2013

Shining a light on night blindness

Vanderbilt researchers are studying how mutations in the receptor for light, rhodopsin, cause light blindness.
By VUMC News and Communications
1 … 76 77 78 79 80 … 104